| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.08. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.08. | WORK Medical Technology Group reports Q2 results | 2 | Seeking Alpha | ||
| 16.06. | WORK Medical announces 1-for-100 reverse stock split | 7 | Seeking Alpha | ||
| 16.06. | WORK Medical Technology Group LTD: WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026 | 683 | GlobeNewswire (Europe) | Auckland, New Zealand, June 16, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, today announced... ► Artikel lesen | |
| 05.06. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 03.06. | Work Medical establishes U.S. subsidiary in Nevada | 4 | Investing.com | ||
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 03.06. | WORK Medical Technology Group LTD: WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy | 407 | GlobeNewswire (Europe) | Hangzhou, China, June 03, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China today announced the... ► Artikel lesen | |
| 27.05. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 14.05. | Morning Market Movers: Robo.ai, Antelope Enterprise Holdings, WORK Medical Technology Group, POET Technologies See Big Swings | 1.422 | AFX News | SAN FRANCISCO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the... ► Artikel lesen | |
| 13.05. | WORK Medical Technology Group Is Trending Overnight - Here's Why WOK Stock Surged Over 69% In After-Hours Session | 19 | Benzinga.com | ||
| 11.05. | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | 168 | GlobeNewswire (Europe) | Hangzhou, China, May 11, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiaries... ► Artikel lesen | |
| 01.05. | WORK Medical Technology Group LTD: WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | 1 | GlobeNewswire (USA) | ||
| 15.04. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 659 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 386 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | 1.140 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 16.10.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025 | 392 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 16, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 14.10.25 | WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq | 337 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 10.10.25 | WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance | 368 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,020 | +2,47 % | Teladoc Aktie setzt Talfahrt fort: Chefjurist geht, Sorgen bleiben | ||
| HIMS & HERS HEALTH | 26,040 | +1,09 % | Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership | Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,069 | +2,38 % | Sernova Biotherapeutics Inc mit PAUKENSCHLAG: Kaufen Insider bereits massiv? - Jetzt unbedingt lesen! | ||
| CERENOME | 1,322 | -10,92 % | Cerenome, Inc.: Cerenome Expects $1.55 Million in CNSide Third Quarter Gross Billings | Lead test on track for 200 million covered lives and beneficiaries by early 2027 after CMS meeting On track to launch expanded CNSide testing menu with multiple tests in Q4 2026 HOUSTON, Sept. 30... ► Artikel lesen | |
| HEALWELL AI | 0,471 | -3,78 % | Cantech Letter: HEALWELL AI to Present at the Cantech Investment Conference on October 8th in Toronto | Toronto, Ontario--(Newsfile Corp. - September 28, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,960 | -6,67 % | Atossa plans shareholder stake in potential PRV proceeds | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | +1,36 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,075 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| ORGANON | 12,165 | -0,25 % | Organon Canada Gets Approval For NDUVRA 1% Non-Steroid Cream For Atopic Dermatitis | ||
| QUIDELORTHO | 9,624 | +0,65 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,525 | 0,00 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 5,850 | 0,00 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,720 | -4,62 % | Clover Health adds two directors to board | ||
| SENSEONICS | 8,700 | -1,14 % | TD Cowen bestätigt Kaufempfehlung für Senseonics Aktie aufgrund von Wachstumstreibern |